Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8590)
All Articles published online
|
Publishing Process of This Article
|
May 6, 2021 (publication date) through Apr 3, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yoon JH, Jung YJ, Moon SH. Immunotherapy for pancreatic cancer. World J Clin Cases 2021; 9(13): 2969-2982 [PMID: 33969083 DOI: 10.12998/wjcc.v9.i13.2969] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v9/i13/2969.htm |
| Number | Citing Articles |
| 1 |
Craig Grobbelaar, Mpho Kgomo, Peace Mabeta. Angiogenesis and Pancreatic Cancer: Novel Approaches to Overcome
Treatment Resistance. Current Cancer Drug Targets 2024; 24(11): 1116 doi: 10.2174/0115680096284588240105051402
|
| 2 |
Udit Basak, Sumon Mukherjee, Sourio Chakraborty, Gaurisankar Sa, Shubhra Ghosh Dastidar, Tanya Das. In-silico analysis unveiling the role of cancer stem cells in immunotherapy resistance of immune checkpoint-high pancreatic adenocarcinoma. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-93924-3
|
| 3 |
Viviana Cortiana, Rabab Hunaid Abbas, Harshal Chorya, Jade Gambill, Diksha Mahendru, Chandler H. Park, Yan Leyfman. Personalized Medicine in Pancreatic Cancer: The Promise of Biomarkers and Molecular Targeting with Dr. Michael J. Pishvaian. Cancers 2024; 16(13): 2329 doi: 10.3390/cancers16132329
|
| 4 |
Julian Burks, Shweta Tiwary, David M Stevens, Sarah L Skoczen, Ruvanthi N Kularatne, Stephan T Stern, Jay A Berzofsky. PLS-α-GalCer: a novel targeted glycolipid therapy for solid tumors. Journal for ImmunoTherapy of Cancer 2025; 13(3): e009539 doi: 10.1136/jitc-2024-009539
|
| 5 |
Simone Donati, Cinzia Aurilia, Gaia Palmini, Irene Falsetti, Teresa Iantomasi, Maria Luisa Brandi. Autophagy-Related ncRNAs in Pancreatic Cancer. Pharmaceuticals 2022; 15(12): 1547 doi: 10.3390/ph15121547
|
| 6 |
Xiuli Xia, Shushan Zhao, Xiaoming Song, Mengyue Zhang, Xinying Zhu, Changjuan Li, Wenting Chen, Dongqiang Zhao. The potential use and experimental validation of genomic instability-related lncRNA in pancreatic carcinoma. Medicine 2023; 102(37): e35300 doi: 10.1097/MD.0000000000035300
|
| 7 |
Murtaza Ahmed, Brent K. Larson, Arsen Osipov, Nilofer Azad, Andrew Hendifar. A case of adenosquamous pancreatic cancer with a KRAS G12C mutation with an exceptional response to immunotherapy. Oncotarget 2024; 15(1): 741 doi: 10.18632/oncotarget.28659
|
| 8 |
Angela Lauriola, Pierpaola Davalli, Gaetano Marverti, Spartaco Santi, Andrea Caporali, Domenico D’Arca. Targeting the Interplay of Independent Cellular Pathways and Immunity: A Challenge in Cancer Immunotherapy. Cancers 2023; 15(11): 3009 doi: 10.3390/cancers15113009
|
| 9 |
思博 陈. Research Progress of Immunotherapy for Pancreatic Malignant Tumors. World Journal of Cancer Research 2025; 15(02): 61 doi: 10.12677/wjcr.2025.152008
|
| 10 |
Chao Yin, Ali Alqahtani, Marcus S. Noel. The Next Frontier in Pancreatic Cancer: Targeting the Tumor Immune Milieu and Molecular Pathways. Cancers 2022; 14(11): 2619 doi: 10.3390/cancers14112619
|
| 11 |
Cheng Yan, Yandie Niu, Feng Li, Wei Zhao, Liukai Ma. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma. Journal of Translational Medicine 2022; 20(1) doi: 10.1186/s12967-022-03632-z
|
| 12 |
Yonghao Xu, Yisu Wang, Qi Chen, Tao Yao, Junyu Qiu, Lei Ni, Hui Chen, Tingbo Liang. A protein-based prognostic model for pancreatic ductal adenocarcinoma: Construction and validation. Pancreatology 2023; 23(8): 1003 doi: 10.1016/j.pan.2023.10.021
|
| 13 |
Manoj Kumar Gupta, Ramakrishna Vadde. Immune Landscape of Pancreatic Cancer Development and Drug Resistance. 2024; : 173 doi: 10.1016/B978-0-443-23523-8.00004-3
|
| 14 |
Thomas Lambin, Cyril Lafon, Robert Andrew Drainville, Mathieu Pioche, Frédéric Prat. Locoregional therapies and their effects on the tumoral microenvironment of pancreatic ductal adenocarcinoma. World Journal of Gastroenterology 2022; 28(13): 1288-1303 doi: 10.3748/wjg.v28.i13.1288
|
| 15 |
Shiyu Liu, Fan Li, Li Deng, Qiongqiong Ma, Wenyi Lu, Zhuoqian Zhao, Huanzhen Liu, Yixuan Zhou, Manli Hu, Hui Wang, Yingbin Yan, Mingfeng Zhao, Hongkai Zhang, Mingjuan Du. Claudin18.2 bispecific T cell engager armed oncolytic virus enhances antitumor effects against pancreatic cancer. Molecular Therapy - Oncolytics 2023; 30: 275 doi: 10.1016/j.omto.2023.08.011
|
| 16 |
Yanyan Kong, Fang Xie, Zhengwei Zhang, Shaobo Wang, Yabin Zhang, Yang Di, Zhongwen Zhou, Donglang Jiang, Junpeng Li, Qi Huang, Jie Wang, Xiuming Li, Zhiwei Pan, Ruiqing Ni, Yihui Guan. Evaluation of novel anti-CEACAM6 antibody-based conjugates for radioimmunotheranostics of pancreatic ductal adenocarcinoma. European Radiology 2023; 33(10): 7077 doi: 10.1007/s00330-023-09679-w
|
| 17 |
Zouina Sarfraz, Azza Sarfraz, Muhammad Danyal Farooq, Musfira Khalid, Khadija Cheema, Faheem Javad, Taleah Khan, Zainab Pervaiz, Muzna Sarfraz, Ali Jaan, Subhan Sadiq, Junaid Anwar. The Current Landscape of Clinical Trials for Immunotherapy in Pancreatic Cancer: A State-of-the-Art Review. Journal of Gastrointestinal Cancer 2024; 55(3): 1026 doi: 10.1007/s12029-024-01078-8
|
| 18 |
Xiao Xu, Xiang Wang, Yu-Pei Liao, Lijia Luo, Andre E. Nel. Reprogramming the Tolerogenic Immune Response Against Pancreatic Cancer Metastases by Lipid Nanoparticles Delivering a STING Agonist Plus Mutant KRAS mRNA. ACS Nano 2025; 19(9): 8579 doi: 10.1021/acsnano.4c14102
|
| 19 |
Belén Toledo, Chiara Deiana, Fabio Scianò, Giovanni Brandi, Juan Antonio Marchal, Macarena Perán, Elisa Giovannetti. Treatment resistance in pancreatic and biliary tract cancer: molecular and clinical pharmacology perspectives. Expert Review of Clinical Pharmacology 2024; 17(4): 323 doi: 10.1080/17512433.2024.2319340
|
| 20 |
Sherin Shaji, Pratikkumar Patel, Umar-Farouk Mamani, Yuhan Guo, Sushil Koirala, Chien-Yu Lin, Mohammed Alahmari, Evanthia Omoscharka, Kun Cheng. Delivery of a STING Agonist Using Lipid Nanoparticles Inhibits Pancreatic Cancer Growth. International Journal of Nanomedicine 2024; : 8769 doi: 10.2147/IJN.S462213
|
| 21 |
Hiromichi Sato, Tomoaki Hara, Sikun Meng, Yoshiko Tsuji, Yasuko Arao, Yoshiko Saito, Kazuki Sasaki, Shogo Kobayashi, Yuichiro Doki, Hidetoshi Eguchi, Hideshi Ishii. Multifaced roles of desmoplastic reaction and fibrosis in pancreatic cancer progression: Current understanding and future directions. Cancer Science 2023; 114(9): 3487 doi: 10.1111/cas.15890
|
| 22 |
Pankti C. Balar, Vasso Apostolopoulos, Vivek P. Chavda. A new era of immune therapeutics for pancreatic cancer: Monoclonal antibodies paving the way. European Journal of Pharmacology 2024; 969: 176451 doi: 10.1016/j.ejphar.2024.176451
|
| 23 |
Xiangying Deng, Xu He, Zehua Yang, Jing Huang, Lin Zhao, Min Wen, Xiyuan Hu, Zizheng Zou. Clustering analysis and prognostic model based on PI3K/AKT-related genes in pancreatic cancer. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1112104
|
| 24 |
Ling-Jen Hung, Chen-Yang Huang, Kai-Che Tung, Jen-Shi Chen, Wen-Kuan Huang, Chih-Chung Hsu, Yueh-Fu Fang, Chih-Liang Wang, Ping-Chi Liu, Kun-Yun Yeh, Pei-Hung Chang, John Wen-Cheng Chang, Yung-Chang Lin, Shiu-Feng Huang, Wen-Chi Chou. Comprehensive genomic profiling in multiple cancer types: A comparative analysis of the National Biobank Consortium of Taiwan and clinical practice cohorts. Journal of the Formosan Medical Association 2024; doi: 10.1016/j.jfma.2024.09.001
|
| 25 |
Imke Stouten, Nadine van Montfoort, Lukas J. A. C. Hawinkels. The Tango between Cancer-Associated Fibroblasts (CAFs) and Immune Cells in Affecting Immunotherapy Efficacy in Pancreatic Cancer. International Journal of Molecular Sciences 2023; 24(10): 8707 doi: 10.3390/ijms24108707
|
| 26 |
Ana Bogut, Bojan Stojanovic, Marina Jovanovic, Milica Dimitrijevic Stojanovic, Nevena Gajovic, Bojana S. Stojanovic, Goran Balovic, Milan Jovanovic, Aleksandar Lazovic, Milos Mirovic, Milena Jurisevic, Ivan Jovanovic, Violeta Mladenovic. Galectin-1 in Pancreatic Ductal Adenocarcinoma: Bridging Tumor Biology, Immune Evasion, and Therapeutic Opportunities. International Journal of Molecular Sciences 2023; 24(21): 15500 doi: 10.3390/ijms242115500
|
| 27 |
Wei Wang, Sujing Zhang, Cong Wang, Siming Gao, Lingling Zhang, Changwang Zhang, Zheng Zheng, Jiancong Zhang, Hui Xu, Changwen Bo, Na Li. Fluorouracil enhances the anti-pancreatic cancer effect of anti-PD-L1 antibodies via up-regulating the expression of PD-L1 in cancer cells. Journal of Investigative Medicine 2025; 73(3): 310 doi: 10.1177/10815589251314192
|
| 28 |
Frederik J. Hansen, Paul David, Marina Akram, Samuel Knoedler, Anke Mittelstädt, Susanne Merkel, Malgorzata J. Podolska, Izabela Swierzy, Lotta Roßdeutsch, Bettina Klösch, Dina Kouhestani, Anna Anthuber, Alan Bénard, Maximilian Brunner, Christian Krautz, Robert Grützmann, Georg F. Weber. Circulating Monocytes Serve as Novel Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma Patients. Cancers 2023; 15(2): 363 doi: 10.3390/cancers15020363
|
| 29 |
Amna Khalid, Sarfraz Ahmad. Immune Landscape of Pancreatic Cancer Development and Drug Resistance. 2024; : 221 doi: 10.1016/B978-0-443-23523-8.00011-0
|
| 30 |
Saira Rafaqat, Huma Khurshid, Ramsha Hafeez, Mehnaz Arif, Ayesha Zafar, Mahrukh Gilani, Habiba Ashraf, Sana Rafaqat. Role of Interleukins in Pancreatic Cancer: A Literature Review. Journal of Gastrointestinal Cancer 2024; 55(4): 1498 doi: 10.1007/s12029-024-01111-w
|
| 31 |
Ali Amirkhosravi, Sarfraz Ahmad. Immune Therapy for Pancreatic and Colon Cancers. 2025; : 245 doi: 10.1016/B978-0-443-24742-2.00027-7
|